Top Companies in the DNA Test Kits Market
- 23andMe
- AncestryDNA
- MyHeritage DNA
- FamilyTreeDNA
- Living DNA
- Nebula Genomics
- Color Genomics
- Invitae
- Natera
- FTDNA / Gene by Gene
- LabCorp
- Quest Diagnostics
- BGI / MGI
- Illumina
- Thermo Fisher Scientific
- Myriad Genetics
- Invivoscribe / Orchid Biosciences
- Prenetics
- Fulgent Genetics
- Eurofins Genomics
Market Growth
The global DNA test kits market size is calculated at USD 1.61 billion in 2024, grew to USD 1.88 billion in 2025, and is projected to reach around USD 7.78 billion by 2034. The market is expanding at a CAGR of 17.04% between 2025 and 2034.
DNA Test Kits Market Trends
- Increasing Collaboration: In August 2024, Qiagen announced the expansion of its partnership with AstraZeneca to explore the use of genomic profiling in chronic diseases beyond cancer. The partnership was made to develop novel genotyping assays based on Qiagen’s QIAstat-Dx multiplex PCR system to offer a rapid companion diagnostic.
- Venture Capital Funding: In June 2024, BillionToOne announced that it raised $130 million in venture capital funding to scale up its DNA testing businesses in non-invasive prenatal screening and cancer. Since the launch of its first test in 2020, over 500,000 patients have been evaluated, driving $125 million in annual revenue.
Value Chain Analysis of the DNA Test Kits Market
R&D
Research activities are conducted to develop innovative DNA test kits to detect unknown biomarkers, optimize DNA extraction and analysis techniques, and interpret data. Novel DNA test kits offer more accuracy, precision, and faster results.
Key Players: 23andMe, Ancestry, and MyHeritage
Clinical Trials & Regulatory Approvals
DNA test kits undergo clinical trials to assess their safety and efficacy. Test kit manufacturers need to receive approval from regulatory agencies to sell their products in the market.
Key Players: QIAGEN Gaithersburg, Inc., ReCode Therapeutics, and Creative Biosciences (Guangzhou) Co., Ltd.
Patient Support & Services
DNA test kits offer patient support and services by enabling genetic information and providing an idea about nutrition and wellness.
Latest Announcement by Industry Leaders
Ms Mary Josephine Rapadas, Director of Gene Solutions Philippines, commented that the company had to send samples to Gene Solutions’ central laboratories in Singapore and Vietnam before partnering with the Medical City (TMC), resulting in longer wait times and higher logistics costs. The collaboration will bring significant benefits and greater accessibility to Filipino patients.
Recent Developments in the DNA Test Kits Market
- In May 2025, Hydreight Technologies, Inc. announced the launch of a new direct-to-consumer genetic testing and personalized wellness solution through its VSDHOne platform. The solution enables patients to access at-home DNA testing kits and receive personalized health plans, such as nutrition, fitness, and medication compatibility.
- In February 2025, Metropolis Healthcare, in collaboration with Roche Diagnostics India and Neighboring Markets, launched a self-sampling human papillomavirus (HPV) DNA test for cervical screening in India. HPV DNA screening is cost-effective and results in reduced follow-ups and fewer tests over a lifetime.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
